Targeted cancer therapy (EGFR tyrosine kinase inhibitor)
Last reviewed June 2026
Who is this for?
Osimertinib (sold as Tagrisso in Nigeria) is a targeted cancer medicine that works by blocking a specific abnormal protein (called EGFR) found on some cancer cells, which stops the cancer from growing and spreading.
Prescription Required
You need a doctor's prescription to buy this drug.
Explore this drug